Supply Issues Johnson & Johnson Medical Ltd Veress Needle FGE3233 (ICN 3257)

• The supply issue with Veress needle products from Johnson & Johnson Medical Ltd is continuing.
• The affected product code remains subject to intermittent supply:
  • FGE3233 – Needle Veress Pneumoperitoneum needle mm length.
• One product code remains affected in total.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• We will update this ICN as soon as we have further information.
• The supply issue is now to be resolved by 31 July 2026.

• The supply issue with Veress needle products from Johnson & Johnson Medical Ltd has improved.
• FGE3234 is now available to order through our online catalogue.
• One product remains subject to intermittent supply:
  • FGE3233 – Needle Veress Pneumoperitoneum needle mm length.
• One product code is now affected in total.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 30 June 2026.

• The supply issue with Veress Needle products from Johnson & Johnson Medical Ltd is continuing.
• One further product is now subject to intermittent supply:
  • FGE3234 – Needle Veress Pneumoperitoneum needle 15mm length.
• One product remains subject to intermittent supply:
  • FGE3233 – Needle Veress Pneumoperitoneum needle mm length.
• Two products are now affected in total.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 30 April 2026.

Change:

• The supplier Johnson & Johnson Medical Ltd has informed us of a supply issue with its Veress Needle.
• There is one product code affected:
  • FGE3233 – Needle Veress Pneumoperitoneum needle mm length.
• The supply issue is due to supplier manufacturing issues.

Impact:

• The affected product is currently subject to intermittent supply.
• Potential direct and indirect alternative products are available to order through our online catalogue:
  • FGE1242 – Veress 120mm Needle
  • FGE6479 – Ultimate Veress Needle 120mm
  • FGE7183 – Veress needle 120mm
  • FGE85226 – Veress needle L:120mm.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 31 March 2026.

Next Steps:              

• Customers are advised to log into our website to view the product listing for further information on the affected product code and potential alternatives.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.